These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23824569)

  • 1. STAT3 is associated with lymph node metastasis in gastric cancer.
    Deng J; Liang H; Zhang R; Sun D; Pan Y; Liu Y; Zhang L; Hao X
    Tumour Biol; 2013 Oct; 34(5):2791-800. PubMed ID: 23824569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
    Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
    Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
    Xu W; Fu J; Wu H; Sun W
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer.
    Deng JY; Sun D; Liu XY; Pan Y; Liang H
    World J Gastroenterol; 2010 Nov; 16(42):5380-7. PubMed ID: 21072904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer.
    Deng J; Jiao X; Liu H; Wu L; Zhang R; Wang B; Pan Y; Hao X; Liang H
    Tumour Biol; 2013 Dec; 34(6):3627-36. PubMed ID: 23824571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
    Chaib I; Karachaliou N; Pilotto S; Codony Servat J; Cai X; Li X; Drozdowskyj A; Servat CC; Yang J; Hu C; Cardona AF; Vivanco GL; Vergnenegre A; Sanchez JM; Provencio M; de Marinis F; Passaro A; Carcereny E; Reguart N; Campelo CG; Teixido C; Sperduti I; Rodriguez S; Lazzari C; Verlicchi A; de Aguirre I; Queralt C; Wei J; Estrada R; Puig de la Bellacasa R; Ramirez JL; Jacobson K; Ditzel HJ; Santarpia M; Viteri S; Molina MA; Zhou C; Cao P; Ma PC; Bivona TG; Rosell R
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
    Seethala RR; Gooding WE; Handler PN; Collins B; Zhang Q; Siegfried JM; Grandis JR
    Clin Cancer Res; 2008 Mar; 14(5):1303-9. PubMed ID: 18316548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
    Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
    Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
    Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
    Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.
    Clay TD; Russell PA; Do H; Sundararajan V; Conron M; Wright GM; Solomon B; Dobrovic A; McLachlan SA; Moore MM
    Med Oncol; 2017 Sep; 34(10):175. PubMed ID: 28879441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
    Gao SP; Mark KG; Leslie K; Pao W; Motoi N; Gerald WL; Travis WD; Bornmann W; Veach D; Clarkson B; Bromberg JF
    J Clin Invest; 2007 Dec; 117(12):3846-56. PubMed ID: 18060032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.
    Woo S; Lee BL; Yoon J; Cho SJ; Baik TK; Chang MS; Lee HE; Park JW; Kim YH; Kim WH
    Pathobiology; 2011; 78(6):295-301. PubMed ID: 22104200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
    Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
    Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
    Dobi E; Monnien F; Kim S; Ivanaj A; N'Guyen T; Demarchi M; Adotevi O; Thierry-Vuillemin A; Jary M; Kantelip B; Pivot X; Godet Y; Degano SV; Borg C
    Clin Colorectal Cancer; 2013 Mar; 12(1):28-36. PubMed ID: 23083634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 activation in tumor cell-free lymph nodes predicts a poor prognosis for gastric cancer.
    Wu LJ; Li HX; Luo XT; Lu RZ; Ma YF; Wang R; Zhang J; Yang DQ; Yu H; Liu J
    Int J Clin Exp Pathol; 2014; 7(3):1140-6. PubMed ID: 24696730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of STAT3, MMP-1 and TIMP-1 in gastric cancer and correlation with pathological features.
    Cai QW; Li J; Li XQ; Wang JQ; Huang Y
    Mol Med Rep; 2012 Jun; 5(6):1438-42. PubMed ID: 22469989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
    Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.
    Kim HS; Park YH; Lee J; Ahn JS; Kim J; Shim YM; Kim JH; Park K; Han J; Ahn MJ
    Cancer; 2010 Feb; 116(3):676-85. PubMed ID: 20052735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
    Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
    Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.